Recently, we have found for the first time that RUNX2 attenuates p53 family-dependent cell death following DNA damage, and RUNX2 gene silencing mediated by siRNA clearly enhances GEM sensitivity of pancreatic cancer cells irrespective of their p53 status [24–27]. Here, RUNX2 is linked to pancreatic neoplasm.